| Similar Articles |
|---|
 |
Pharmaceutical Executive
August 1, 2012
Jill Wechsler |
Fleshing Out FDASIA Medical apps, e-submissions, counterfeit drugs, and imports tucked into fairly "clean" user-fee renewal legislation. In late June leading legislators reached across party lines to quickly approve the Food and Drug Administration Safety and Innovation Act.   |
Pharmaceutical Executive
March 1, 2012
Ron Cohen |
FDA's Necessary Dose of Reality There's no fast-acting salve, but there are several steps that can be taken to streamline many of the procedures at FDA. And it begins with leadership. |
CIO
August 27, 2013
Brian Eastwood |
Healthcare IT Struggles to Keep Up With Mobile Health Demands While healthcare struggles with unique legal and regulatory impediments that other fields don't face, it's also poised to gain much more from what some call a 'mobile revolution.' |
Pharmaceutical Executive
February 1, 2014
Longacre et al. |
Social Media: Have We Reached The Tipping Point? For pharma marketers, the good news is recent advances in social media monitoring make it possible to listen to or engage with patients on social media websites. This month FDA released its draft guidance on the use of "Interactive Promotional Media." |
InternetNews
September 9, 2010 |
Apple Relents on App Store Guidelines, Developer Rules Mobile app creators get greater flexibility in the tools they use and more visibility into Apple's approval process. |
Bio-IT World
April 15, 2003
Janet Woodcock |
FDA Director Explains the Changes The head of the Center for Drug Evaluation and Research discusses why the FDA is now kinder and gentler about Part 11 compliance. |
InternetNews
March 10, 2010 |
Google Unveils Apps Marketplace Google debuts online shop for apps, expanding beyond its own App Engine to offer developers working in other frameworks an integration into the marketplace. |
CRM
February 2012
Leonard Klie |
Location-Based Services Find Their Place in Mobile Apps E-commerce apps are a big piece of the development landscape. |
Chemistry World
July 2007
Victoria Gill |
Conflict of interest? The FDA has been questioned after a published study brought exposed cardiovascular risks associated with GlaxoSmithKline's diabetes drug, Avandia. |
Bio-IT World
August 13, 2003
Brian Reid |
Remaking the FDA New commissioner is pushing for greater use of technology and innovation to speed the flow of drugs to market. |
The Motley Fool
July 8, 2008
Brian Lawler |
Blockbuster Drugs Bound for Extinction? One of the biggest classes of prescription drugs, those for diabetes treatments, faces tougher FDA standards. |
The Motley Fool
August 28, 2010
Daniel Bailey |
App Store Crosses 250,000 Apps It's been little more than two years and Apple's app store is receiving some 600 new apps every day. |
The Motley Fool
October 3, 2010
Gabriel Perna |
Apps Come Into Their Own Mobile apps are huge, and they're poised to get even bigger. |
Chemistry World
May 23, 2012
Andy Extance |
Drug watchdogs mark out global territory The US Food and Drug Administration has published plans to ensure that American citizens continue to enjoy access to safe drugs, even as the regulatory pressures of globalization grow. |
PC Magazine
March 23, 2011
Lance Ulanoff |
Is There a Cure for Bad Apps? For better or worse, this is the new world of application creation, delivery, and access. Companies like Apple, Microsoft, Google, and RIM are now the gate keepers. They're not perfect, though. |
InternetNews
November 12, 2009 |
Apple Gives iPhone Developers App Status Tracker Apple is taking a step toward shining some light on its iPhone application vetting process by providing a new way for app developers to track the status of programs they've submitted to the company's App Store. |
Pharmaceutical Executive
February 1, 2012
Jennifer Ringler |
Industry Trees are Falling, But is FDA Around to Hear? Experts weigh in on FDA's long-awaited social media guidelines. |
InternetNews
March 12, 2009
Stuart J. Johnston |
Microsoft's Mobile Storefront Has Familiar Terms Developers for the next generation of Windows Mobile applications will find terms similar to what Apple charges. |
PC Magazine
July 14, 2010 |
The Top 100 Free Apps for Your Phone 2010 Supercharge your iPhone, Android, BlackBerry or other smartphone with the 100 best free apps. |
Pharmaceutical Executive
April 1, 2011 |
Off-Label But On Point? Use of off-label drugs is a balancing act for physicians, and poses even more problems for pharma. The FDA is moving slowly to help. |
Pharmaceutical Executive
March 1, 2013
Jill Wechsler |
Another Round of FDA Legislation? Pressure for action on key enforcement and regulatory issues may prompt congressional action this year. |
The Motley Fool
January 14, 2008
Brian Lawler |
Score One for Dendreon and Disclosure A prestigious journal supports Dendreon's potential prostate cancer treatment, and makes a compelling case for more FDA disclosure. |
Pharmaceutical Executive
August 1, 2008
Jill Wechsler |
Can Sentinel Save Drug Development? FDA's new sentinel system shows the pendulum swing toward safety won't swing back anytime soon. |
Pharmaceutical Executive
December 1, 2011
Jill Wechsler |
FDA Gets a New Look Agency expansion and globalization promote innovation, collaboration, and organizational changes |
InternetNews
March 22, 2010 |
Apple Sounds the Call for iPad Developers Developers can get approval for their apps before the device's official launch - but the clock's ticking. |
The Motley Fool
March 5, 2008
Brian Orelli |
FDA (Indirectly) Thwacks Amylin The FDA's draft guidance puts a cloud of uncertainty over the makers of diabetes drugs. |
CIO
September 18, 2012
Jeff Vance |
Free Mobile Apps Put Your BYOD Strategies at Risk When it comes to the BYOD trend, CIOs worry over their lack of control of mobile apps. However, it's not only about rogue mobile apps packing malware that trouble them. IT leaders are also concerned by the risks posed by malware-free mobile apps. |
Pharmaceutical Executive
February 1, 2006
Jill Wechsler |
Washington Report: Cross-Agency Collaboration for Part D Medicare Part D gives CMS more clout over coverage, pricing, and even drug development. |
Chemistry World
September 24, 2010
Andrew Turley |
End of the road for Avandia? The European Medicines Agency has decided the troubled diabetes drug should be pulled from the market while the US Food and Drug Administration has said it will 'significantly restrict' its use. |
Fast Company
January 9, 2012
Adam Bluestein |
As Smartphones Get Smarter, You May Get Healthier: How mHealth Can Bring Cheaper Health Care To All Smartphones and tablets are transforming the future of health care. Can we really trust them to save lives? |
Pharmaceutical Executive
January 1, 2006
Kenneth I. Kaitin |
Opinion: Memo to von Eschenbach FDA's acting commissioner has an opportunity to clarify a lot of misconceptions about the agency's role in regulating drug safety. His first order of business should be to explain exactly what FDA doesn't do. |
Pharmaceutical Executive
January 1, 2014
Jill Wechsler |
Pharma Challenges for 2014 Pricing and personalized medicine are key themes shaping drug development and marketing |
The Motley Fool
March 7, 2005
Brian Gorman |
Glaxo in Hot Water Glaxo's problems with the FDA could have been avoided. Investors can only hope that the FDA is in a forgiving mood. |
HBS Working Knowledge
November 17, 2003
Martha Lagace |
The Politics of Innovation Mark B. McClellan, the new commissioner of the Food and Drug Administration, described what the FDA is doing to bridge the gap between the high cost of innovation and patients' demand for lower prices. |
BusinessWeek
November 4, 2010
Rachael King |
Mobile Apps Suit Up for Work Companies are creating in-house app stores for their employees. |
IndustryWeek
October 19, 2011 |
FDA: A Future Innovation Partner? Could the Food and Drug Administration reform itself to help manufacturers create new medical technologies? |
InternetNews
September 17, 2010 |
Windows Phone 7 App Tools Released for Devs Microsoft reaches out to developers as part its ongoing push to build momentum and applications for Windows Phone 7 slated to ship later this year. |
IEEE Spectrum
October 2011
Joseph M. Smith |
Wireless Health Care Wireless technologies are about to transform health care, and not a moment too soon |
Pharmaceutical Executive
February 1, 2006
Bryan Luce |
Back Page: Taking Hold of the Wheel Healthcare decision makers do not consistently consider drugs' value. FDA needs to be pressured to change its stance on communicating economic evidence. |
Pharmaceutical Executive
July 3, 2007
Louis A. Morris |
Culture Shock The withdrawal of Vioxx signaled a sea change. Welcome to the Culture of Drug Safety. The FDA is making changes in the way it reviews drug safety. Post-marketing staff has been enlarged 25%, and new, tougher laws are on the way. |
Pharmaceutical Executive
June 1, 2005
Michael Parisi |
Direct to Consumer: Patient-Reported Outcomes New clinical endpoints mean exacting messages for patients. Physicians and other healthcare professionals can use these tools now as they attempt to evaluate the effectiveness of treatments and optimize drug utilizations to combat the high cost of drug treatment. |
InternetNews
March 31, 2011 |
Windows Phone 7 Tools Downloaded 1.5 Million Times While Microsoft is claiming it has nearly 12 thousand apps for Windows Phone 7 already, it's trying to keep developers focused on writing more. |
The Motley Fool
April 7, 2011
Cindy Johnson |
A Cloudy Future for Smartphones and Tablets A shift to cloud-based apps could level the playing field. |
Bio-IT World
December 15, 2003
Kevin Davies |
The Road to Personalized Medicine FDA guidance on the road to genomic medicine is a welcome first step in what promises to be a contentious debate on how to integrate pharmacogenomics into routine medical practice. |
HBS Working Knowledge
August 10, 2015
Michael Blanding |
New Medical Devices Get To Patients Too Slowly The FDA has streamlined drug testing to ensure new therapies come to market quickly. But when it comes to life-giving medical devices, approvals seem unnecessarily slow, according to research by Ariel Dora Stern. |
The Motley Fool
August 20, 2011
Luke Timmerman |
Seattle Genetics Wins FDA Approval of First Drug FDA gives a quick turnaround on the new treatment for lymphomas. |
The Motley Fool
July 30, 2010
Wade Roush |
OpenAppMkt: The Return of the iPhone Web App? Let the apps flow! |
Chemistry World
April 24, 2008
James Mitchell Crow |
FDA takes tough line on biologic drug The US Food and Drug Administration has rejected an application from biotechnology firm Genzyme to make its already-approved, protein-based drug Myozyme in larger batches. |
Bio-IT World
August 13, 2003
John Rhodes |
Beyond the Blockbuster Genomics and big hits are not mutually exclusive, writes Deloitte & Touche's life sciences expert. |
InternetNews
July 28, 2010 |
Mobile Apps Are Hot, But Are They Safe? The proliferation of mobile apps for the smartphone market is big business but security experts are warning that many of the apps are built on third-party code that may not be properly vetted for security risks. |
